79 -9 (59) 2023 - Elmurodova A.A. - IMMUNOLOGICAL PARAMETERS OF CHANGES OBSERVED IN THE LIVER IN HDV INFECTION

IMMUNOLOGICAL PARAMETERS OF CHANGES OBSERVED IN THE LIVER IN HDV INFECTION

Elmurodova A.A. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Viral hepatitis remains the most urgent problem of global public health. Every year, infectious diseases are the cause of death in more than 4 million people, about 1 million people die from hepatitis B (HBV) and C (HCV) in the world every year, and even more people infected with these viruses lose their ability to work. Losses associated with viral hepatitis account for a significant share of the economic damage from the most common infectious diseases. Against the background of rapid progress in the treatment of viral hepatitis C, the role of insufficiently studied and difficult to treat mixed hepatitis B infection with delta agent is currently increasing.

Keywords: hepatitis D, hepatitis B, epidemiology, cirrhosis of the liver, procalcitonin

First page

437

Last page

440

For citation: Elmurodova A.A. – IMMUNOLOGICAL PARAMETERS OF CHANGES OBSERVED IN THE LIVER IN HDV INFECTION//New Day in Medicine 2023 9(59): 437-440 https://newdaymedicine.com/index.php/2023/10/18/l-465/

LIST OF REFERENCES:

  1. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. //J. Hepatol. 2012;57:167-185.
  2. Abdurahmanov DT, Chronic hepatitis V i D (Chronic hepatitis B and D), M., GEOTAR Media, 2010;288.
  3. Rizzetto M., Alessia C. Epidemiology of Hepatitis D. Semin. Liver. Dis. 2012;32:211-219.
  4. Kaliaskarova KS Faktoryi progressirovaniya hronicheskih virusnyih gepatitov V, S v korennoy populyatsii Kazakhstan : avtoreferat dis. Dr. med. nauk - Karaganda, 2010; 24 p.m.
  5. Degertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int. 2008;28(4):494-8.
  6. Nersesov AV, i dr. Rasprostranennost virusnyih gepatitov sredi zhiteley Yuzhno-Kazahstanskoy oblasti (The prevalence of viral hepatitis among residents of the South Kazakhstan region), Medicine (Almaty). 2016; 9(171):30-33.
  7. Hazanov AI, Vasilev AP, Pehtashev SG i dr. Znachenie osnovnyih i dobavochnyih etiologicheskih faktorov v razvitii HBV- i HCV-tsirrozov pecheni (The importance of the main and additional etiological factors in the development of HBV and HCV cirrhosis), Ros. zhurn. gastroenterol. hepatol. koloproktl. 2001;4:8-12.
  8. Amosov AD, Gepatit V: inform.-method. Posobie, A.D. Amosov. M., 2006;100-103.
  9. Kaliaskarova KS, Primenenie Pegintrona pri 1b genotipe hronicheskogo gepatita S u kazahov (The use of Pegintron at 1b genotype of chronic hepatitis C in Kazakhs), Meditsinskiy vestnik Severnogo Kavkaza, 2008;3:13-14.
  10. Rizzetto M. Hepatitis D: Thirty years after. J. Hepatol. 2009;50:1043-1050.

    file

    download